Published in Transfusion on September 01, 1992
Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev (1997) 4.70
Yersinia enterocolitica and white cell filtration. Transfusion (1992) 3.39
Rapid identification of Yersinia enterocolitica in blood by the 5' nuclease PCR assay. J Clin Microbiol (2000) 1.22
Transfusion-associated bacterial sepsis. Clin Microbiol Rev (1994) 1.22
Bacteriological and serological findings in a further case of transfusion-mediated Yersinia enterocolitica sepsis. J Clin Microbiol (2000) 0.83
Current evidence for human yersiniosis in Ireland. Eur J Clin Microbiol Infect Dis (2012) 0.76
Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med (1998) 4.69
Transfusion medicine. First of two parts--blood transfusion. N Engl J Med (1999) 4.21
Transfusion medicine. Second of two parts--blood conservation. N Engl J Med (1999) 2.95
Current status of solvent/detergent-treated frozen plasma. Transfusion (1998) 2.24
Embryonic-fetal erythroid characteristics of a human leukemic cell line. Proc Natl Acad Sci U S A (1980) 1.90
Single-concentration broth microdilution test for detection of high-level aminoglycoside resistance in enterococci. J Clin Microbiol (1987) 1.85
Extended storage of red blood cells under anaerobic conditions. Vox Sang (2007) 1.82
Phenotypic characteristics of coliform and noncoliform bacteria from a public water supply compared with regional and national clinical species. Appl Environ Microbiol (1986) 1.79
Fecal carriage of Streptococcus bovis and colorectal adenomas. Gastroenterology (1991) 1.65
Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study. Transfusion (1996) 1.65
Occult polymicrobial endocarditis with Haemophilus parainfluenzae in intravenous drug abusers. Am J Med (1989) 1.57
Transfusion to blood group A and O patients of group B RBCs that have been enzymatically converted to group O. Transfusion (2000) 1.49
Non-infectious complications of transfusion therapy. Blood Rev (2001) 1.47
Analysis of the relative safety of autologous blood units available for transfusion to homologous recipients. Transfusion (1988) 1.43
The value and limitations of the Gram stain examination in the diagnosis of intraamniotic infection. Am J Obstet Gynecol (1988) 1.42
The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion (2003) 1.41
Universal leucocyte-depletion of blood components: cell concentrates and plasma. Vox Sang (2001) 1.39
Cytokine generation in stored platelet concentrates. Transfusion (1994) 1.35
The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion (1993) 1.34
Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sang (2004) 1.22
hADA3 is required for p53 activity. EMBO J (2001) 1.22
Bacteriophages as indicators of enteric viruses and public health risk in groundwaters. J Appl Microbiol (2000) 1.15
Occurrence of the release reaction during preparation and storage of platelet concentrates. Vox Sang (1981) 1.14
Diagnostic role of tests for T cell receptor (TCR) genes. J Clin Pathol (2003) 1.14
Pathogen inactivation techniques. Best Pract Res Clin Haematol (2006) 1.12
Purified JC virus T and T' proteins differentially interact with the retinoblastoma family of tumor suppressor proteins. Virology (2000) 1.11
In vitro diagnostic assays are effective during the acute phase of delayed-type drug hypersensitivity reactions. Br J Dermatol (2013) 1.11
The myth of the ultimate blood safety wall. Transfusion (2001) 1.08
Universal WBC reduction. Transfusion (2000) 1.06
Effects of 3-5 log10 pre-storage leucocyte depletion on red cell storage and metabolism. Br J Haematol (1994) 1.05
Localized neuropathy following jellyfish sting. Postgrad Med J (1990) 1.05
Two-dimensional gel electrophoresis and immunoblotting of Campylobacter outer membrane proteins. Infect Immun (1987) 1.05
Senile cardiac amyloidosis associated with homozygosity for a transthyretin variant (ILE-122). J Lab Clin Med (1991) 1.00
Aminoglutethimide (with hydrocortisone) induced agranulocytosis in primary breast cancer. Br Med J (Clin Res Ed) (1985) 0.96
Endocarditis caused by relatively penicillin-resistant Stomatococcus mucilaginosus. J Clin Microbiol (1989) 0.94
Impact of various red cell concentrate preparation methods on the efficiency of prestorage white cell filtration and on red cells during storage for 42 days. Transfusion (1998) 0.93
Platelet storage solution affects on the accuracy of laboratory tests for platelet function: a multi-laboratory study. Vox Sang (2004) 0.93
Carotid endarterectomy under local anesthesia in elderly: is it worthwhile? Acta Biomed (2005) 0.93
Effect of storage time on clinical efficacy of single-donor platelet units. Transfusion (1993) 0.93
Clinical and molecular basis of transfusion-induced immunomodulation: summary of the proceedings of a state-of-the-art conference. Transfus Med Rev (2001) 0.93
Cytokine generation in stored, white cell-reduced, and bacterially contaminated units of red cells. Transfusion (1995) 0.92
Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting. Ann Thorac Surg (1994) 0.89
Plasma fibronectin level and clinical status in cardiac surgery patients. J Lab Clin Med (1983) 0.88
Detection of bacterial contamination of platelet concentrates. Vox Sang (2007) 0.88
Letter: Abuse of salt "substitute". N Engl J Med (1975) 0.87
Chemotactic peptide binding by intact neutrophils from human neonates. Pediatr Res (1984) 0.87
Storage of platelets in additive solutions: a multicentre study of the in vitro effects of potassium and magnesium. Vox Sang (2003) 0.87
Activation in stored platelet concentrates: correlation between membrane expression of P-selectin, glycoprotein IIb/IIIa, and beta-thromboglobulin release. Transfusion (1993) 0.86
[Metronidazole sensitivity of anaerobes. A comparison with other chemotherapeutics (author's transl)]. MMW Munch Med Wochenschr (1980) 0.86
Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. The HIV Blood Donor Study Group. Transfusion (1997) 0.86
Isolation and flow cytometric analysis of T-cell-depleted CD34+ PBPCs. Transfusion (2000) 0.85
The effect of mode of agitation and type of plastic bag on storage characteristics and in vivo kinetics of platelet concentrates. Transfusion (1986) 0.84
Interlaboratory comparison of red-cell ATP, 2,3-diphosphoglycerate and haemolysis measurements. Vox Sang (2005) 0.84
Metastatic carcinoma of the breast. An unusual presentation mimicking cutaneous vasculitis. Cancer (1987) 0.84
Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescue. Br J Haematol (2000) 0.83
Recommended methods for conducting radiolabeled platelet survival studies. Transfusion (1986) 0.83
Oxygen-detoxifying enzymes in neutrophils of infants and their mothers. J Lab Clin Med (1980) 0.83
Endovascular procedures in critical leg ischemia of elderly patients. Acta Biomed (2005) 0.83
Role of microaggregate blood filtration in clinical medicine. Transfusion (1984) 0.83
Activation of platelet concentrate during preparation and storage. Blood Cells (1992) 0.82
Extended storage of platelets in a new plastic container. II. In vivo response to infusion of platelets stored for 5 days. Transfusion (1985) 0.82
Viability and in vitro properties of AS-1 red cells after gamma irradiation. Transfusion (1999) 0.82
Inventory management. Vox Sang (2010) 0.81
Ingestion of hydroxyethyl starch by human leukocytes. Transfusion (1986) 0.81
Activation and activity of the superoxide-generating system of neutrophils from human infants. Pediatr Res (1983) 0.81
The cellular and molecular basis of the platelet storage lesion: a symposium summary. Transfusion (1992) 0.80
Effects of white cell reduction on the resistance of blood components to bacterial multiplication. Transfusion (1994) 0.80
Safety of transcranial magnetic stimulation. Lancet (1990) 0.80
Detection of drug-dependent, platelet-reactive antibodies by solid-phase red cell adherence assays. Br J Haematol (1997) 0.80
Effect of mode of agitation on storage of platelet concentrates in PL-732 containers for 5 days. Vox Sang (1983) 0.80
Antibody elution using citric acid. Transfusion (1986) 0.79
In vitro and in vivo evaluation of platelet transfusions administered through an electromechanical infusion pump. Am J Clin Pathol (1990) 0.79
Apoptosis in transfusion medicine: of death and dying--is that all there is? Transfusion (2000) 0.79
A prospective, randomized study of the use of platelet concentrates irradiated with ultraviolet-B light in patients with hematologic malignancy. Transfusion (1996) 0.79
In vitro characteristics of volume-reduced platelet concentrate stored in syringes. Transfusion (1991) 0.79
Positive role of Clostridium difficile infection in diarrhea in infants and children. Am J Gastroenterol (1991) 0.79
An in vivo evaluation of microaggregate blood filtration during total hip replacement. Ann Surg (1979) 0.79
Autologous blood perfusion for myocardial protection during coronary angioplasty: a feasibility study. Circulation (1987) 0.79
Evaluation of a new prestorage leukoreduction filter for red blood cell units. Vox Sang (1997) 0.78
Making risk statements stick. Vox Sang (2002) 0.78
Topical platelet growth factor therapy: of lotions and potions. Transfusion (2001) 0.78
Storage of platelets in additive solutions: a pilot in vitro study of the effects of potassium and magnesium. Vox Sang (2002) 0.78
Breast tumor contamination of PBSC harvests: tumor depletion by positive selection of CD34(+) cells. Cytotherapy (2001) 0.78
[Acute pelvic inflammatory disease: comparison of therapeutic protocols]. Minerva Ginecol (1996) 0.78
Presumed immune thrombocytopenia and carcinoma: report of three cases and review of the literature. Am J Med Sci (1980) 0.78
In vitro characteristics of white cell-reduced single-unit platelet concentrates stored in syringes. Transfusion (1994) 0.78
Removal of anaphylatoxins C3a and C5a and chemokines interleukin 8 and RANTES by polyester white cell-reduction and plasma filters. Transfusion (1998) 0.78
Effect of blood transfusion on in vivo levels of plasma fibronectin. J Lab Clin Med (1981) 0.77
Making Landsteiner's discovery superfluous: safety and economic implications of a universal group O red blood cell supply. Transfus Sci (1997) 0.77
Microaggregate blood filtration in patients with compromised pulmonary function. Transfusion (1982) 0.77
Use of polyester filters for the preparation of leukocyte-poor platelet concentrates. Vox Sang (1988) 0.77